In order to comprehensively advance public health and strengthen strategies for the prevention and treatment of major diseases, medical innovation and international collaboration have become pivotal forces in overcoming critical health challenges. Against this backdrop, the 2026 Beijing International Hematopoietic Stem Cell Transplantation Symposium (Art of Transplant: Beijing Hematopoietic Stem Cell Transplantation Symposium, AOT 2026), hosted by the Hematology Branch of the China International Exchange and Promotive Association for Medical and Health Care, and organized by the National Clinical Research Center for Hematologic Diseases and the Institute of Hematology at Peking University, will be grandly held in Beijing on April 24–25, 2026.Under the theme “The Art of Transplantation,” this year’s symposium will bring together leading experts in hematology from around the world to engage in in-depth discussions on technological innovations and future directions in hematopoietic stem cell transplantation. Key topics will include the optimization of clinical practices in allogeneic transplantation, transplantation strategies for special populations, and the prevention and management of transplant-related complications. In addition, the conference will feature two parallel forums—clinical case discussions and cutting-edge research—aimed at exploring critical pathways for translating basic research into clinical applications.
Beijing, a city where tradition meets modernity, has long served as a vital nexus of scientific inquiry and humanistic care. We warmly invite colleagues from across the globe to gather here, where technology transcends borders and life remains paramount. Together, let us chart a global blueprint for regenerative medicine—bridging boundaries with advanced solutions and advancing medical wisdom for the benefit of all—infusing new momentum into the vision of a “Healthy China” and a global community of shared health for humanity.
